Β-sympathomimetics, inhalative
DefinitionThis section has been translated automatically.
Sympathomimetics used for bronchial or nasal application.
IndicationThis section has been translated automatically.
- Rhinitis allergica for short-term (3-5 days) symptomatic relief of nasal congestion.
- Bronchial asthma, demand-oriented.
Limited indicationThis section has been translated automatically.
Pregnancy, children < 3 years, arteriosclerosis, diabetes mellitus, cardiac arrhythmia, severe hypertension, thyroid disease, pheochromocytoma, taking MAO-A inhibitors, fresh myocardial infarction.
Undesirable effectsThis section has been translated automatically.
Drug addiction, optical and acoustic hallucinations, nervousness, sleep disorders, subtle tremor, blurred vision, cardiac arrhythmia, impaired nasal breathing, dryness of the nose, nasal burning, damage to the nasal mucosa during long-term use, allergic reactions.
InteractionsThis section has been translated automatically.
See Table 1.
ContraindicationThis section has been translated automatically.
Hypersensitivity to the active substance, severe heart disease, ozaena, rhinitis sicca.
TablesThis section has been translated automatically.
Major interactions of inhaled β-sympathomimetics.
Anesthetics |
Reciprocal toxicity ↑ |
Antidepressants, tricyclic |
Blood pressure elevation |
Guanethidine |
Blood pressure elevation |
Insulin |
Reciprocal toxicity ↑ |
MAO-A inhibitors, irreversible |
RR drop, cardiac arrhythmias, avoid combination. |
Hyperglycemia |
|
Propanolol |
Reciprocal toxicity ↑ |
Reserpine |
Blood pressure elevation |
Hyperglycemia |